Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rang în acțiuni #24454
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Preț acțiune
$0.78611575
Capitalizare de piață
$60.45M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-12.06%
Țară
NO
Tranzacționează Lytix Biopharma AS (LYTIX)

Categorie

Prețul LYTIX cu capitalizarea de piață a B
Lytix Biopharma AS Lytix Biopharma AS
LYTIX
$0.78611575
Capitalizarea de piață a Lytix Biopharma AS(LYTIX)
Capitalizare de piață: $60.45M
În anul August 2026, Lytix Biopharma AS are o capitalizare de piață de $60.45M. Acest lucru face ca Lytix Biopharma AS să fie a 24454th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Lytix Biopharma AS din 2021 până în 2026
LYTIX în comparație cu top 5 cele mai populare stocks
Prețul pentru LYTIX Activul B Capitalizarea de piață a B Rezultate
Lytix Biopharma AS Lytix Biopharma AS
$67,754.55 $60.45M
$5.210T +8,618,802.12%
Lytix Biopharma AS Lytix Biopharma AS
$59,123.77 $60.45M
$4.547T +7,520,900.56%
Lytix Biopharma AS Lytix Biopharma AS
$53,939.86 $60.45M
$4.148T +6,861,466.80%
Lytix Biopharma AS Lytix Biopharma AS
$46,497.08 $60.45M
$3.576T +5,914,688.66%
Lytix Biopharma AS Lytix Biopharma AS
$36,143.30 $60.45M
$2.779T +4,597,606.72%